Biblio
Identification of 2-fluoropalmitic acid as a potential therapeutic agent against glioblastoma. Curr Pharm Des. 2020.
Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming. Stem Cell Reports. 2022;17(8):1799-1809.